IL162350A0 - Preparation of cis-fused 3,3a,8,12b-tetrahydro-2h-dibenzo Ä3,4:6.7ÜcycloheptaÄ1,2-bÜfuran derivatives - Google Patents

Preparation of cis-fused 3,3a,8,12b-tetrahydro-2h-dibenzo Ä3,4:6.7ÜcycloheptaÄ1,2-bÜfuran derivatives

Info

Publication number
IL162350A0
IL162350A0 IL16235002A IL16235002A IL162350A0 IL 162350 A0 IL162350 A0 IL 162350A0 IL 16235002 A IL16235002 A IL 16235002A IL 16235002 A IL16235002 A IL 16235002A IL 162350 A0 IL162350 A0 IL 162350A0
Authority
IL
Israel
Prior art keywords
büfuran
dibenzo
tetrahydro
cis
fused
Prior art date
Application number
IL16235002A
Other languages
English (en)
Original Assignee
Janssen Pharmaceutica Nv
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Janssen Pharmaceutica Nv filed Critical Janssen Pharmaceutica Nv
Publication of IL162350A0 publication Critical patent/IL162350A0/xx

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D307/00Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
    • C07D307/77Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D307/93Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom ortho- or peri-condensed with carbocyclic rings or ring systems condensed with a ring other than six-membered
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/06Antimigraine agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/18Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/22Anxiolytics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/24Antidepressants
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/28Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/30Drugs for disorders of the nervous system for treating abuse or dependence

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Psychiatry (AREA)
  • Pain & Pain Management (AREA)
  • Addiction (AREA)
  • Hospice & Palliative Care (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Furan Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
IL16235002A 2001-12-07 2002-12-02 Preparation of cis-fused 3,3a,8,12b-tetrahydro-2h-dibenzo Ä3,4:6.7ÜcycloheptaÄ1,2-bÜfuran derivatives IL162350A0 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP01204962 2001-12-07
PCT/EP2002/013561 WO2003048147A2 (fr) 2001-12-07 2002-12-02 Preparation de derives de 3,3a,8,12b-tetrahydro-2$i(h)-dibenzo[3,4:6,7]cyclohepta[1,2-b]furanes fusionnes en cis

Publications (1)

Publication Number Publication Date
IL162350A0 true IL162350A0 (en) 2005-11-20

Family

ID=8181461

Family Applications (1)

Application Number Title Priority Date Filing Date
IL16235002A IL162350A0 (en) 2001-12-07 2002-12-02 Preparation of cis-fused 3,3a,8,12b-tetrahydro-2h-dibenzo Ä3,4:6.7ÜcycloheptaÄ1,2-bÜfuran derivatives

Country Status (16)

Country Link
US (1) US7205335B2 (fr)
EP (1) EP1463722A2 (fr)
JP (1) JP2005511692A (fr)
KR (1) KR20050044334A (fr)
CN (1) CN1697833A (fr)
AU (1) AU2002352205A1 (fr)
BR (1) BR0214775A (fr)
CA (1) CA2468040A1 (fr)
HR (1) HRP20040489A2 (fr)
HU (1) HUP0402325A2 (fr)
IL (1) IL162350A0 (fr)
MX (1) MXPA04005399A (fr)
NO (1) NO20042883L (fr)
PL (1) PL370440A1 (fr)
WO (1) WO2003048147A2 (fr)
ZA (1) ZA200404392B (fr)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NZ532806A (en) * 2001-12-07 2006-01-27 Janssen Pharmaceutica Nv Preparation of trans-fused 3,3a,8,12b-tetrahydro-2H-dibenzo[3,4:6,7]cyclohepta[1,2-b]furan derivatives
JP2008511582A (ja) 2004-08-31 2008-04-17 ジヤンセン・フアーマシユーチカ・ナームローゼ・フエンノートシヤツプ [2−(4−フルオロ−ベンジル)−フェニル]−酢酸の製造方法
WO2006061392A2 (fr) 2004-12-07 2006-06-15 Janssen Pharmaceutica N.V. Nouveaux derives insatures tetracycliques de tetrahydrofurane, pyrrolidine et tetrahydrothiophene
NZ564181A (en) 2005-06-17 2010-02-26 Janssen Pharmaceutica Nv Novel tetracyclic tetrahydrofuran derivatives containing a cyclic amine side chain
BR112014031471B1 (pt) 2012-07-17 2020-12-01 Dow Global Technologies Llc composição líquida, uso da composição líquida, dispersão sólida, processo para produzir a dispersão sólida e processo para revestir uma forma de dosagem
KR102160903B1 (ko) * 2012-07-17 2020-10-05 다우 글로벌 테크놀로지스 엘엘씨 고도로 치환된 하이드록시알킬 메틸셀룰로즈를 포함하는 고체 분산물

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TR199801164T2 (xx) 1996-04-12 1998-10-21 Janssen Pharmaceutica N.V. S�bstit�e edilmi� tetrasiklik tetrahidrofuran t�revleri.
UA52778C2 (uk) 1997-10-10 2003-01-15 Янссен Фармацевтика Н.В. Галогенозаміщені тетрациклічні похідні тетрагідрофурану, спосіб їх отримання та композиція на їх основі

Also Published As

Publication number Publication date
PL370440A1 (en) 2005-05-30
WO2003048147A3 (fr) 2004-04-01
NO20042883L (no) 2004-07-07
CA2468040A1 (fr) 2003-06-12
MXPA04005399A (es) 2004-10-11
EP1463722A2 (fr) 2004-10-06
CN1697833A (zh) 2005-11-16
HRP20040489A2 (en) 2005-04-30
US7205335B2 (en) 2007-04-17
HUP0402325A2 (hu) 2005-02-28
BR0214775A (pt) 2004-11-09
WO2003048147A2 (fr) 2003-06-12
KR20050044334A (ko) 2005-05-12
ZA200404392B (en) 2005-09-27
AU2002352205A1 (en) 2003-06-17
JP2005511692A (ja) 2005-04-28
US20050033067A1 (en) 2005-02-10

Similar Documents

Publication Publication Date Title
AU2002361992A1 (en) 1,4-dihydro-1,4-diphenylpyridine derivatives
IL160708A0 (en) 1, 6-naphthyridine derivatives as antidiabetics
HK1061852A1 (en) 4,5-dihydro-ih-pyrazole derivatives having cb1-antagonistic activity
IL160081A0 (en) Novel 4,5-dihydro-1h-pyrazole derivatives having cb1-antagonistic activity
IL161881A (en) N,n'-substituted-1,3-diamino-2- hydroxypropane derivatives
IL157704A0 (en) 4,5-dihydro-1h-pyrazole derivatives having potent cbi-antagonistic activity
HK1062911A1 (en) Substituted 2-pyridine-cyclohexane-1,4-diamine derivatives
AU2001230026A1 (en) 2,4-diaminothiazole derivatives
AU2002367323A1 (en) Benzothieno (3,2-
AU2001269063A1 (en) Shortened synthesis of 3,3-diarylpropylamine derivatives
MXPA03009206A (es) FORMULACIONES DE 3,7-DIAZABICICLO [3.3.1] COMO COMPUESTOS ANTIARRiTMICOS.
ZA200109206B (en) Preparation of substituted piperidin-4-ones.
AU2002303529A1 (en) Antidepressant azaheterocyclylmethyl derivatives of 1,4,5-trioxa-phenanthrene
IL162350A0 (en) Preparation of cis-fused 3,3a,8,12b-tetrahydro-2h-dibenzo Ä3,4:6.7ÜcycloheptaÄ1,2-bÜfuran derivatives
AU2002330042A1 (en) Process for the preparation of 1,5-diarylpyrazoles
IL162188A0 (en) Process for the preparation of Ä1,4,5Ü-oxadiazepine derivatives
MXPA03008394A (es) Derivados de biuretano.
HK1066022A1 (en) Use of 1,1,1,3,3-pentafluorobutan
PL366629A1 (en) 3,7-diazabicyclo [3.3.1] formulations as anti-arrythmic compounds
MXPA03006162A (es) Derivados de mikanolida, su preparacion y sus usos terapeuticos.
EP1295864A4 (fr) Procede de preparation de 1,5-diaminonaphtalenes
IL159965A0 (en) Novel 2,4-diaminothiazole derivatives
HK1041606A1 (en) Process for the preparation of n,n'-carbonylbislactams.
AU2002233181A1 (en) Novel, 2,5-diazabicyclo[2.2.1]heptane derivatives
EG23305A (en) Preparation of 1,2-dicloroethane.